Cancer patients who received mRNA-based COVID vaccines within 100 days of starting treatment with widely used immunotherapies ...

The researchers found that mRNA-based COVID-19 vaccines could potentially help patients whose tumors don’t respond well to ...

WASHINGTON (AP) — The most widely used COVID-19 vaccines may offer a surprise benefit for some cancer patients – revving up ...

Cancer patients who received the mRNA-based jab after starting immunotherapy lived significantly longer than those who did ...

People with advanced skin and lung cancers who received mRNA Covid-19 vaccines within 100 days of starting immunotherapy ...

RNA vaccines seem to boost the effectiveness of an immune therapy for skin and lung cancer ― in an unexpected way.

Researchers at UF Health and the University of Texas MD Anderson have found that cancer patients may live longer if they ...

Patients with cancer who received mRNA-based COVID vaccines within 100 days of starting immune checkpoint therapy were twice ...

A new study from MD Anderson Cancer Center shows cancer patients who received mRNA-based COVID vaccines within 100 days of ...

A study published in Nature looks at COVID-19 mRNA vaccines and the immune response to tumours during immunotherapy. Prof Andrew Beggs, MRC Senior Clinical Fellow and Consultant Colorectal Surgeon, ...

A new study suggests that mRNA vaccines for COVID-19 could help boost the effects of immunotherapy drugs for some cancer patients.

NEW YORK – BioNTech said Wednesday that it began an exchange offer to complete its $1.25B all-stock acquisition of mRNA immunotherapy developer CureVac, a deal that was announced in June.